Corporate ActionJul 6, 2026, 11:51 AM
Park Ha Biological to Increase Share Capital, Boost Class B Voting Rights
AI Summary
Park Ha Biological Technology Co., Ltd. will hold an Extraordinary General Meeting and a Class A Meeting on July 13, 2026, to seek shareholder approval for several significant corporate actions. Key proposals include a substantial increase in the company's authorized share capital from US$3 million to US$300 million, and authorization for the Board to implement share consolidations or subdivisions within a three-year period. Additionally, shareholders will vote on increasing the voting rights of Class B Ordinary Shares from 20 to 100 votes per share, and adopting new Articles of Association.
Key Highlights
- Shareholders to vote on increasing authorized share capital from $3M to $300M.
- Authorized share capital to increase from 3 billion to 300 billion ordinary shares.
- Board authorized to effect share consolidations (reverse splits) between 2-for-1 and 5,000-for-1.
- Board authorized to effect share subdivisions (splits) between 2-for-1 and 100-for-1.
- Proposal to increase Class B Ordinary Share voting rights from 20 to 100 votes per share.
- New Amended and Restated Memorandum and Articles of Association to be adopted.
Price Impact
More from BYAH